Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84574339)
Watch
English
Dose-dense chemotherapy in advanced ovarian cancer
scientific article published on 18 September 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
title
Dose-dense chemotherapy in advanced ovarian cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
main subject
ovarian cancer
1 reference
based on heuristic
inferred from title
author name string
Michael A Bookman
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
language of work or name
English
0 references
publication date
18 September 2009
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
volume
374
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
issue
9698
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
page(s)
1303-1305
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
cites work
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly paclitaxel in the adjuvant treatment of breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is inhibition of cancer angiogenesis and growth by paclitaxel schedule dependent?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961305-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(09)61305-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
PubMed publication ID
19767094
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19767094
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767094%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
